...
首页> 外文期刊>American journal of otolaryngology >Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: A 14-year review.
【24h】

Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: A 14-year review.

机译:T4喉癌的全喉切除术和术后放疗:14年回顾。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: The most appropriate treatment of locally advanced carcinoma of the larynx remains to be ascertained. Management of T4 laryngeal cancer patients with postoperative radiotherapy after total laryngectomy is generally advocated and not often debated. However, the effects of this combined treatment approach are poorly documented. We reviewed the oncologic outcome and long-term survival of individuals treated by total laryngectomy and postoperative radiotherapy (TLPR) for T4 carcinoma of the larynx. METHODS: Twenty-eight patients with a pathologic diagnosis of T4 laryngeal cancer treated by TLPR during a 14-year period were studied retrospectively. Median follow-up from treatment until the end of observation was 36 months (range 6 to 123 months). RESULTS: The overall actuarial and disease-free survival rates at 7 years were 43% and 30%, respectively. Local recurrence, regional relapse, and distant metastasis developed in 4%, 4%, and 7% of the cases, respectively. Later esophageal stricture, dental caries, or carotid artery disease in 3 patients (11%) was successfully managed. Multivariate analysis showed patient age, bilateral true vocal cord-anterior commissure involvement by laryngeal cancer (horse-shoe lesion), and any type of treatment failure to be the most predictive variables affecting prognosis. CONCLUSION: Long-term disease control and survival is achievable by TLPR with minimal late toxicity in patients with T4 carcinoma of the larynx.
机译:目的:仍需确定最合适的局部晚期喉癌治疗方法。通常提倡对T4喉癌患者进行全喉切除术后术后放疗的管理,这一点很少引起争议。但是,这种联合治疗方法的效果文献很少。我们回顾了经喉全切除术和术后放疗(TLPR)治疗的T4喉癌患者的肿瘤学结局和长期存活率。方法:回顾性研究了14年来经TLPR治疗的28例经病理诊断为T4喉癌的患者。从治疗到观察结束的中位随访时间为36个月(范围6至123个月)。结果:7年总精算和无病生存率分别为43%和30%。局部复发,局部复发和远处转移分别占4%,4%和7%。后来成功治疗了3例(11%)的食道狭窄,龋齿或颈动脉疾病。多因素分析显示,患者年龄,喉癌(马蹄型皮损)累及双侧真正的声带-前连合以及任何类型的治疗失败都是影响预后的最预测变量。结论TLPR可实现T4喉癌患者的长期疾病控制和生存,且后期毒性最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号